Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-9090 in Advanced Esophagogastric Cancers
NCT01167114Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2010
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in Esophagogastric Cancer, sponsored by Massachusetts General Hospital. Started Aug 2010; status: completed.
02
Drugs
ganetespib
03
Conditions
Esophagogastric Cancer
Beyond the preview
Go deeper on NCT01167114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167114.